Abbott Laboratories ABT
NYSE ABT
$105.42 -0.10 (-0.09%)
As of: Sep 9, 2026 · 3:30 PM EDT

Abbott Laboratories (ABT) Capital Expenditures Growth (5y) (2014 - 2026)

Analysis

Abbott Laboratories (ABT) Capital Expenditures Growth (5y) (2014 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 183.54 Bn 177.93 Bn 7.27 Bn
2 Intuitive Surgical 124.70 Bn 119.48 Bn 1.96 Bn
3 Medtronic 117.91 Bn 109.09 Bn 6.34 Bn
4 Stryker 105.72 Bn 102.25 Bn 4.50 Bn
5 Boston Scientific 66.27 Bn 65.73 Bn 3.85 Bn
6 Edwards Lifesciences 49.52 Bn 45.27 Bn 1.35 Bn
7 Alcon 33.89 Bn 32.43 Bn 1.68 Bn
8 Dexcom 32.10 Bn 30.15 Bn 830.00 Mn
9 Steris 21.06 Bn 20.58 Bn 684.20 Mn
10 Zimmer Biomet Holdings 18.26 Bn 17.85 Bn 1.54 Bn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 3.77%
Mar 31, 2026 0.10%
Dec 31, 2025 0.29%
Sep 30, 2025 0.00%
Jun 30, 2025 -4.80%
Mar 31, 2025 6.10%
Dec 31, 2024 10.65%
Sep 30, 2024 6.75%
Jun 30, 2024 2.64%
Mar 31, 2024 3.51%
Dec 31, 2023 10.08%
Sep 30, 2023 9.61%
Jun 30, 2023 11.21%
Mar 31, 2023 6.68%
Dec 31, 2022 12.07%
Sep 30, 2022 12.17%
Jun 30, 2022 8.25%
Mar 31, 2022 3.37%
Dec 31, 2021 13.99%
Sep 30, 2021 8.12%